Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.62 |
| ▸ | SLC1A2 | P43004 | 7/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 6/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 7/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 11/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 8/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.37 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.36 |
| ▸ | GRIK3 | Q13003 | 3/20 | 0.36 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.35 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leucine SCHEMBL28948522 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL138874 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL2408752 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL1863461 | 0.97 | SLC7A5 (0.58) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL7759799 | 0.97 | SLC7A5 (0.58) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL4294625 | 0.95 | SLC7A5 (0.69) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL122271 | 0.95 | SLC7A5 (0.69) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL3314487 | 0.95 | SLC7A5 (0.69) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL18249997 | 0.95 | SLC7A5 (0.69) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL1537205 | 0.95 | SLC7A5 (0.69) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 588 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903324-B | Pharmaceutical preparation for targeted degradation of hepatitis B virus X protein and application thereof | 珠海市人民医院 | 2024-07-23 | — | — | CN | disclosed |
| US-20240158865-A1 | Markers of Triple-Negative Breast Cancer and Uses Thereof | VANDERBILT UNIVERSITY | 2024-05-16 | — | — | US | disclosed |
| CN-117903324-A | Pharmaceutical preparation for targeted degradation of hepatitis B virus X protein and application thereof | 珠海市人民医院 | 2024-04-19 | — | — | CN | disclosed |
| WO-2024074847-A1 | COMPOSITIONS FOR DETECTING BIOLOGICAL AGENTS | PATH SPRAY LTD (GB) | 2024-04-11 | — | — | WO | disclosed |
| WO-2024069176-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN ACTIVATING EXOGENOUS PROTEASE CLEAVAGE SITE | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024069191-A1 | CLOSTRIDIAL NEUROTOXIN FOR USE IN A TREATMENT OF BLADDER PAIN SYNDROME | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024069175-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN ACTIVATING ENDOSOMAL PROTEASE CLEAVAGE SITE | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024057031-A1 | CELL-FREE CLOSTRIDIAL NEUROTOXIN ASSAYS | IPSEN BIOPHARM LIMITED (GB) | 2024-03-21 | — | — | WO | disclosed |
| EP-4313120-A1 | TREATMENT OF PAIN & INFLAMMATORY DISORDERS | Ipsen Biopharm Limited (GB) | 2024-02-07 | — | — | EP | disclosed |
| EP-4312964-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN EXOGENOUS ACTIVATION LOOP | Ipsen Biopharm Limited (GB) | 2024-02-07 | — | — | EP | disclosed |
| WO-1997025424-A1 | OB PROTEIN RECEPTOR AND RELATED COMPOSITIONS AND METHODS | AMGEN INC. (US) | 1997-07-17 | — | — | WO | disclosed |
| EP-0745125-A1 | HEMATOPOIETIC PROTEIN AND MATERIALS AND METHODS FOR MAKING IT | ZymoGenetics, Inc. (US) | 1996-12-04 | — | — | EP | disclosed |
| EP-0723456-A1 | METHODS FOR STIMULATING ERYTHROPOIESIS USING THROMBOPOIETIN | THE UNIVERSITY OF WASHINGTON (US) | 1996-07-31 | — | — | EP | disclosed |
| WO-1996020955-A1 | PURIFIED THROMBOPOIETIN AND METHOD OF MAKING IT | ZYMOGENETICS, INC. (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996017067-A1 | METHOD FOR SECRETING THROMBOPOIETIN POLYPEPTIDES | ZYMOGENETICS, INC. (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1996017062-A1 | LOW MOLECULAR WEIGHT THROMBOPOIETIN | ZYMOGENETICS, INC. (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1995021920-A1 | HEMATOPOIETIC PROTEIN AND MATERIALS AND METHODS FOR MAKING IT | ZYMOGENETICS, INC. (US) | 1995-08-17 | — | — | WO | disclosed |
| WO-1995021626-A1 | METHODS FOR STIMULATING ERYTHROPOIESIS USING THROMBOPOIETIN | UNIVERSITY OF WASHINGTON (US) | 1995-08-17 | — | — | WO | disclosed |
| WO-1994028018-A2 | SYNTHETIC STERICALLY-CONSTRAINED CATALYSTS | ATASSI ZOUHAIR (US) | 1994-12-08 | — | — | WO | disclosed |
| CN-1095481-A | Measure juvenile cell reagent | TOA MEDICAL ELECTRONICS (JP) | 1994-11-23 | — | — | CN | disclosed |